Prognostic biomarkers in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy-Reference-Cited by-同舟云学术

Prognostic biomarkers in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy

Published:2014-10-04 Issue:11 Volume:105 Page:1435-1441
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Yamaguchi Motoko¹,Takata Katsuyoshi²,Yoshino Tadashi²,Ishizuka Naoki³,Oguchi Masahiko⁴,Kobayashi Yukio⁵,Isobe Yasushi⁶,Ishizawa Kenichi⁷,Kubota Nobuko⁸,Itoh Kuniaki⁹,Usui Noriko¹⁰,Miyazaki Kana¹,Wasada Izumi¹¹,Nakamura Shigeo¹²,Matsuno Yoshihiro¹³,Oshimi Kazuo¹⁴,Kinoshita Tomohiro¹⁵,Tsukasaki Kunihiro⁹,Tobinai Kensei⁵

Affiliation:

1. Department of Hematology and Oncology Mie University Graduate School of Medicine Tsu Japan

2. Department of Pathology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

3. Clinical Trial Department Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan

4. Department of Radiation Oncology Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan

5. Department of Hematology National Cancer Center Hospital Tokyo Japan

6. Department of Hematology Juntendo University School of Medicine Tokyo Japan

7. Department of Hematology and Rheumatology Tohoku University Hospital Sendai Japan

8. Department of Hematology Saitama Cancer Center Ina Japan

9. Division of Hematology and Oncology National Cancer Center Hospital East Kashiwa Japan

10. Division of Hematology and Oncology Jikei University School of Medicine Tokyo Japan

11. Department of Hematology Tokai University Isehara Japan

12. Department of Pathology and Laboratory Medicine Nagoya University Hospital Nagoya Japan

13. Department of Surgical Pathology Hokkaido University Hospital Sapporo Japan

14. Department of Internal Medicine Kushiro Chuo Hospital Kushiro Japan

15. Department of Hematology and Cell Therapy Aichi Cancer Center Hospital Nagoya Japan

Funder

National Cancer Center Research and Development Fund

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12526

Reference36 articles.

1. Presence of HTLV-I proviral DNA in patients with adult T-Cell leukemia/lymphoma in Taiwan

2. Extranodal NK/T-cell Lymphoma, Nasal Type, Includes Cases of Natural Killer Cell and αβ, γδ, and αβ/γδ T-cell Origin

3. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma;Life;2021-08-16

Optimal Courses of Chemotherapy Combined with Radiotherapy for Low-Risk Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Propensity Score Matching Analysis

;Therapeutics and Clinical Risk Management;2020-12

3. EBV‐encoded RNA1‐positive cells in the bone marrow specimens of patients with EBV‐negative lymphomas and sarcomas;Pathology International;2019-07

4. c‐Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T‐cell lymphoma;Journal of Cellular Biochemistry;2019-03

5. Extranodal NK-/T-Cell Lymphomas and EBV+ Lymphoproliferative Diseases of Childhood;Non-Hodgkin's Lymphoma in Childhood and Adolescence;2019